SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-09-044065
Filing Date
2009-07-21
Accepted
2009-07-21 16:41:54
Documents
7
Period of Report
2009-07-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-19254_18k.htm 8-K 30062
2 EX-99.1 a09-19254_1ex99d1.htm EX-99.1 202516
3 EX-99.2 a09-19254_1ex99d2.htm EX-99.2 32383
4 GRAPHIC g192541mq01i001.jpg GRAPHIC 1461
5 GRAPHIC g192541mmi001.jpg GRAPHIC 1319
6 GRAPHIC g192541mmi002.gif GRAPHIC 1973
7 GRAPHIC g192541mmi003.gif GRAPHIC 2625
  Complete submission text file 0001104659-09-044065.txt   277309
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 09955372
SIC: 2834 Pharmaceutical Preparations